NCT04613362

Brief Summary

The goal of this pilot study is to evaluate a bundle of implementation strategies at three Veteran Affairs Medical Centers (VAMCs) to facilitate the referral and adoption of a telehealth based, cognitive behavioral therapy program delivered by Health Psychologists for Veterans with chronic migraine to inform a future fully-powered hybrid type 2 effectiveness-implementation design. Veteran patients will be randomized to either the telehealth delivered CBT or usual care. Headache symptoms and severity will be reported using a VA text messaging application.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2021

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 27, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 3, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

April 22, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 29, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2023

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

September 19, 2024

Completed
Last Updated

September 19, 2024

Status Verified

August 1, 2024

Enrollment Period

2 years

First QC Date

October 27, 2020

Results QC Date

July 8, 2024

Last Update Submit

August 16, 2024

Conditions

Keywords

Implementation ScienceTelehealthCognitive Behavioral Therapy

Outcome Measures

Primary Outcomes (4)

  • Number of Headache Days at 3 Months

    Daily self-reported migraine headaches using a VA text message protocol

    3 Months after Baseline

  • Budget Impact Analysis - Cost of Training (Implementation)

    Costs associated with program implementation

    2 years

  • Budget Impact Analysis - Time

    Time associated with program implementation

    2 years

  • Budget Impact Analysis - Cost Per Veteran

    Costs associated with intervention per Veteran

    2 years

Other Outcomes (9)

  • Migraine-Specific Quality of Life Questionnaire (MSQ)

    3 months, 6 months

  • Migraine Disability Assessment (MIDAS)

    3 and 6 months

  • Headache-specific Pain Catastrophizing Scale (HPCS)

    3 and 6 months

  • +6 more other outcomes

Study Arms (2)

TENACITY Telehealth Cognitive Behavioral Therapy for Migraine

EXPERIMENTAL

Six sessions of standardized Cognitive Behavioral Therapy for patients with diagnosed chronic migraine headaches will be delivered by a clinical health psychologist via telehealth platform. All patients have access to a set of standardized educational, headache self-management materials.

Behavioral: TENACITY Telehealth Cognitive Behavioral Therapy for Migraine

Behavioral Usual Care

ACTIVE COMPARATOR

Behavioral usual care may include outpatient clinic-based health psychology in the VA or Community Care, or mindfulness sessions with LCSW. Behavioral usual care will be delivered by clinicians for patients with diagnosed chronic migraine.

Behavioral: Behavioral Usual Care

Interventions

Clinical health psychology therapy delivered via telehealth

TENACITY Telehealth Cognitive Behavioral Therapy for Migraine

Behavioral usual care may include outpatient clinic-based health psychology in the VA or Community Care, or mindfulness sessions with LCSW.

Behavioral Usual Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Veteran patients eligible to participate must have:
  • A chronic migraine headache ICD-10 diagnosis;
  • Completion of at least 28 headache diary days;
  • A confirmed frequency of at least 8 headache days per month;
  • A primary complaint of headache

You may not qualify if:

  • Veteran patients not eligible to participate include:
  • Non-Veterans;
  • Veteran patients without a CM headache ICD-10 diagnosis;
  • Veteran patients whose primary pain complaint is not headache;
  • Veteran patients who have received greater than or equal to 90 days of opioid therapy for chronic low back pain from the date of chart screening;
  • Veteran patients who do not speak English;
  • Veteran patients who have a current diagnosis of severe cognitive impairment indicated by clinical provider, medical chart, or Short Portable Mental Status Questionnaire (SPMSQ);
  • Veteran patients who have Post Traumatic headache;
  • Veteran patients who have a diagnosis of cluster headache, other primary headache, post-whiplash headache, secondary headache, or trigeminal autonomic cephalalgia.
  • Any patients currently suffering from a disabling psychiatric illness (as noted by clinician);
  • Veteran patients who self-report Traumatic Brain Injury less than or equal to 1 year before diagnosis of Chronic Migraine, or worsening of Chronic Migraine.
  • Veteran patients who relate daily suicidal ideation within the last 2 weeks as indicated by the PHQ-9 with an answer of "3" to question nine;
  • Veteran patients who have severe depression, as indicated by PHQ-9 score greater than or equal to 20;
  • Veteran patients who are deemed by clinicians who are unable to participate in this trial;
  • Patients who are terminally ill (life expectancy of \<12 months as noted by clinician);
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Birmingham VA Medical Center, Birmingham, AL

Birmingham, Alabama, 35233, United States

Location

VA Connecticut Healthcare System West Haven Campus, West Haven, CT

West Haven, Connecticut, 06516, United States

Location

Richard L. Roudebush VA Medical Center, Indianapolis, IN

Indianapolis, Indiana, 46202-2884, United States

Location

VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX

Dallas, Texas, 75216, United States

Location

Related Publications (2)

  • Goldman RE, Damush TM, Kuruvilla DE, Lindsey H, Baird S, Riley S, Burrone Bs L, Grinberg AS, Seng EK, Fenton BT, Sico JJ. Essential components of care in a multidisciplinary headache center: Perspectives from headache neurology specialists. Headache. 2022 Mar;62(3):306-318. doi: 10.1111/head.14277. Epub 2022 Mar 16.

  • Seng EK, Fenton BT, Wang K, Lipton RB, Ney J, Damush T, Grinberg AS, Skanderson M, Sico JJ. Frequency, Demographics, Comorbidities, and Health Care Utilization by Veterans With Migraine: A VA Nationwide Cohort Study. Neurology. 2022 Oct 31;99(18):e1979-e1992. doi: 10.1212/WNL.0000000000200888.

MeSH Terms

Conditions

Migraine Disorders

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Limitations and Caveats

Limitations include not reaching the target number of participants needed to achieve sufficient statistical power. We initially consented 80 participants of which 57 of the 80 were eligible to be randomized based on the 30 day headache diary outcomes confirming chronic headache. The study was conducted during the COVID-19 pandemic. Thus, the enhanced headache usual treatment was often offered via telehealth.

Results Point of Contact

Title
Dr. Teresa Damush
Organization
Richard L. Roudebush VA Medical Center

Study Officials

  • Teresa M. Damush, PhD

    Richard L. Roudebush VA Medical Center, Indianapolis, IN

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The participant will be randomized by mode of delivery to the telehealth or TAU treatment stratified by site (VA Medical Center). Upon completion of the baseline evaluation, the project coordinator will assign random assignment. The research assistants will be masked to random assignment.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: This is a randomized, controlled feasibility pilot with a single intervention arm, and a usual care control arm. The intervention arm includes participation in the TENACITY telehealth cognitive behavioral therapy CBT program for headache plus education. The usual care arm includes behavioral treatment as usual which may include outpatient clinic-based health psychology in the VA or in the community, or mindfulness sessions by LCSW.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 27, 2020

First Posted

November 3, 2020

Study Start

April 22, 2021

Primary Completion

April 29, 2023

Study Completion

May 31, 2023

Last Updated

September 19, 2024

Results First Posted

September 19, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will share

After the study completion and the planned and secondary analyses are published by the study team, a limited de-identified data set will be made available upon request for a limited period.

Time Frame
To be determined

Locations